Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

viatris healthcare limited - azelastina - azelastina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

haleon italy s.r.l. - azelastina - azelastina

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - pegfilgrastimum - soluzione iniettabile in siringa preriempita - pegfilgrastimum 6 mg, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 20.4 µg, sorbitolum 30 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml. - neutropenia - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 8 mg corresp. hydromorphonum 7.12 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 7.02 mg, hypromellosum, e 172 (nigrum), lactosum 0.012 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 4.36 mg, hypromellosum, e 171, e 172 (rubrum), triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 16 mg corresp. hydromorphonum 14.24 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 15.21 mg, hypromellosum, e 172 (nigrum), lactosum 0.026 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 6.79 mg, hypromellosum, e 171, e 172 (flavum), triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 32 mg corresp. hydromorphonum 28.48 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 172 (flavum), e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 14.04 mg, hypromellosum, e 172 (nigrum), lactosum 0.024 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 10 mg, hypromellosum, e 171, triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 4 mg corresp. hydromorphonum 3.56 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 172 (flavum), e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 8.19 mg, hypromellosum, e 172 (nigrum), lactosum 0.014 mg, cellulosi acetas, macrogolum 3350, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - rivastigminum - cerotto transdermico - rivastigminum 6,9 mg, excipiens per la preparazione per il 4.6 cm2 con la liberazione di 4,6 mg/24 ore. - demenza di tipo alzheimer - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - rivastigminum - cerotto transdermico - rivastigminum di 13,8 mg, excipiens per la preparazione per la 9.2 cm2 con la liberazione di 9,5 mg/24 ore. - demenza di tipo alzheimer - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - rivastigminum - cerotto transdermico - rivastigminum 19.2 mg, excipiens ad praeparationem pro 12.8 cm² cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika